课题基金 / 基金详情

Etiology and pathophysiology of thrombosis : A molecular biological aproach to elucidate disturbed mechanisms of blood coagulation and its inhibition.

Etiology and pathophysiology of thrombosis : A molecular biological aproach to elucidate disturbed mechanisms of blood coagulation and its inhibition.
血栓形成的病因学和病理生理学:一种分子生物学方法,用于阐明凝血及其抑制的紊乱机制。
批准号:
08407034
负责人:
MATSUDA Michio
金额:
$15.23万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

MATSUDA Michio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
I.Analyses of hereditary dysfibnnogens : During the three year-term of studies supported by the Grant-in-Aid for Scientific Research, No. 08407034, we were able to analyze more than 10 abnormal fibrinogen molecules, some of which had been associated with clinical manifestations of either bleeding or thrombosis, or both. Fibrinogen (Fbg) Caracas II with a unique Aalpha Ser-434 to Asn substitution, to which an extra oligosaccharide is linked (J Biol Chem 266 : 11575-11581, 1991) was further studied by electron microscopy (EM). The Caracas II fibrin fibers are found to be loosely associated and fibrin gels appeared to consist of irregularly aligned fibrin bundles with scattering large caves and pores. The permeability experiment showed a high permeability rate as compared with normal fibrin gels (J Biol Chem 271 : 4946-4953, 1996). On the other hand, Fbg Marburg (truncation of 150 amino acids in the Aalpha-chain and partly linked with serum albumin) associated with severe postoperative bl … More eeding accompanied by successive recurrent thrombo-embolic complications was found to partly linked with one or two serum albumin molecules by EM as anticipated by SDS-PAGE.The fibrin gels are composed of extremely thin and highly branched fibrin fibers, forming extraordinarily compact gels. These fibrin clots account for thrombo-embolic complications together with bleeding due to delayed fibrin clot formation. Part of these data was published in BLOOD (91 : 3282-3288,1998), and the remainder is now in preparation for publication. Four other abnormal Fbg's were also characterized and published (Kurashiki : gamma Gly-268 to Glu, Blood 87 : 4686-4694, 1996 ; Kumamoto : Aalpha Arg-19 to Gly, Jpn J Thromb Hemost 8 : 382-392, 1997 ; Kamogawa : gammaArg-275 to Ser, Thromb Haemostas, in press ; Niigata : Bbeta Asn-160 to Ser with an extra oligosaccharide N-linked to Bbeta Asn-158 ; Blood, in press). In three other dysfibrinogens, we have also identified new types of point mutations, Fbg's Pretoria (gamma Cys-139 to Tyr) ; Tokyo V (gammaAla-327 to Thr) and Osaka VI (12 amino acid extension due to the stop codon TAA to AAA for Lys). Further analyses on these molecules are going on, and will be submitted for publication.II.Molecular mechanisms of fibrin (Fbn) to function as adhesion molecule : Fbg functions as adhesion molecule only after transition to fibrin. When human fibroblasts were cultured on a fibrin monolayer, the bi-integrin as well as the already known beta3-integrin was expressed on the cell surface, and spreading of cells progressed in an RGD-dependent manner (J Biol Chem 272 : 8824-8829, 1997). When human glioma cells were cultured, a two-step mode of spreading via the beta1 -integrin was noted : firstly with fibrin (Aalpha RGD 572-574) and then with the autologous fibronectin secreted and incorporated in the extra-cellular matrix. These findings are now in the status of"in press" in Thrombosis Research. Furthermore, plasma kininogen was found to behave not only as an adhesion molecule but also as an inhibitor. These opposing effects were characterized and published (J Biochem 124 : 473-484, 1998). Less
期刊论文(84)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
松田道生: "フィブリノゲンの誘導体,とくに可溶性フィブリン(soluble fibrin)とDダイマー(D dimer)について : その生成と存在様式についての考察.その1.可溶性フィブリン" 日本血栓止血学会誌. 8. 24-32 (1997)
Michio Matsuda:“关于纤维蛋白原衍生物,特别是可溶性纤维蛋白和 D 二聚体:对其形成和存在方式的考虑。第 1 部分。可溶性纤维蛋白”日本血栓和止血学会杂志 8. 24-32 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
MUTO, Terukazu: "Factor XIII supplement therapy-effects on disturbances of wound healing." Med.Progr.10. 16-19 (1997)
MUTO、Terukazu:“因子 XIII 补充疗法 - 对伤口愈合障碍的影响。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
SUGO, Teruko: "Factor XIIIa-cross-linking of the Marburg Fibrin : Formation of αm・γ n-heteromultimers and the α-chain-linked albumin・γ complex, and disturbed protofibril assembly resulting in acquisition of plasmin-resistance relevant to thrombophilia." B
SUGO,Teruko:“马尔堡纤维蛋白的 XIIIa 因子交联:αm·γ n-异多聚体和 α-链连接的白蛋白·γ 复合物的形成,以及原纤维组装的紊乱,导致获得与血栓形成倾向相关的纤溶酶抗性.“B
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
68
    Molecular basis for the fibrinogen structure and functions-Analysis Of hereditary dysfibrinogens and their application to the study
    • 批准号:
      11694308
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $2.11万
    • 财政年份:
      1999
    • 负责人:
      MATSUDA Michio
    • 依托单位:
    STUDIES ON THE PATHOPHYSIOLOGY OF THROMBOEMBOLIC DISEASES WITH SPECIAL REFERENCE TO THE UNDERLYING IMPAIRED BLOOD COAGULATION AND ITS REGULATION
    • 批准号:
      11470250
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $7.81万
    • 财政年份:
      1999
    • 负责人:
      MATSUDA Michio
    • 依托单位:
    Molecular basis for the fibrinogen structure and functions - Analysls of hereditary dysfibrinogens and their application to the study
    • 批准号:
      10044316
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $1.15万
    • 财政年份:
      1998
    • 负责人:
      MATSUDA Michio
    • 依托单位:
    Molecular basis for the fibrinogen structure and functions-Analysis of hereditary dysfibrinogens and their application to the study
    • 批准号:
      09044329
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $1.66万
    • 财政年份:
      1997
    • 负责人:
      MATSUDA Michio
    • 依托单位:
    海外基金